此外，继续停牌。Narnia Group (08607) has announced that since the beginning of 2024, due to changes in the external environment, the demand for general health and life science products has significantly declined.
Therefore, by developing general health business, including the commercialization, manufacturing, and distribution of biotechnology and healthcare products, and providing healthcare services, the business risks have also increased accordingly.
The board of directors hereby notifies that, in order to save management expenses, the company has decided to cancel an inactive subsidiary company, Huzhou Lituo Import and Export Co., Ltd, which holds 51% indirectly.
In addition, the trading of the shares remains suspended.